Coronavirus conserved sequence

Coronavirus conserved sequences are genomic or proteomic regions that remain relatively unchanged across different species and variants of the Coronaviridae family, including SARS-CoV, MERS-CoV, and SARS-CoV-2 (V'kovski et al., 2021, Nature Reviews Microbiology). These sequences often encode proteins essential for the viral life cycle, such as the RNA-dependent RNA polymerase (RdRp), the main protease (Mpro/3CLpro), and the S2 subunit of the spike protein (Malik, 2020, Journal of Family Medicine and Primary Care). Because these regions are functionally constrained, they are less likely to tolerate mutations, making them ideal targets for broad-spectrum antiviral drugs and universal vaccines (Saunders et al., 2021, Nature). Therapeutic agents like remdesivir and nirmatrelvir exploit these conserved sites to inhibit viral replication and processing across multiple coronavirus strains (Owen et al., 2021, Science). Targeting these invariant elements is a key strategy for developing "variant-proof" medical countermeasures against current and future pandemic threats (Morens et al., 2022, NEJM). The conservation of these sequences allows for the design of small molecules and antibodies that maintain efficacy despite the rapid evolution of the virus. However, the development of such therapies requires balancing potency against a wide range of viral targets while minimizing off-target effects on host cellular processes.

Other names

Conserved coronavirus genomic regionsPan-coronavirus targetsInvariant viral sequencesConserved coronavirus motifsConserved viral elements

Inhibition of viral RNA-dependent RNA polymerase (RdRp), inhibition of viral main protease (Mpro), and inhibition of viral membrane fusion (V'kovski et al., 2021; Owen et al., 2021).